Apple Intelligence Will Not Be Launched With iOS 18 Update - 1

Photo Omid Armin on Unsplash

Apple Intelligence Will Not Be Launched With iOS 18 Update

  • Written by Andrea Miliani Former Tech News Expert
  • Fact-Checked by

“Apple Intelligence will arrive later than anticipated, coming in iOS 18.1 and iPadOS 18.1 in October and missing the initial September releases. Still, 18.1 will go into beta for developers this week,” shared Gurman in a post on X.

NEW: Apple Intelligence will arrive later than anticipated, coming in iOS 18.1 and iPadOS 18.1 in October and missing the initial September releases. Still, 18.1 will go into beta for developers this week. https://t.co/LqXDvjO6ef — Mark Gurman (@markgurman) July 28, 2024

Apple Intelligence was the highlight of Apple’s most recent event, and is one of the most important updates this year. The technology is expected to add innovative features to iPhones, Macs, and iPads, enhance Siri and integrate ChatGPT. However, according to Mashable , Apple is not ready to release it to the public yet as it needs more time to fix bugs.

Mashable explains that Apple never gave official dates and that the company only suggested a release for fall. However, many users were expecting the new product soon, integrated with the new OS update, as a beta version of the iOS 18 had already been released days ago.

This delay could also affect the new iPhone 16 software, as Apple suggested that the new iPhones would have Apple Intelligence already integrated.

Many users have shared their support for the tech giant’s decision to delay the release on social media. “With something as groundbreaking and deeply integrated as Apple Intelligence, it is preferable that it be extremely polished upon release,” wrote one user on X . Developers who will be able to test the new AI product in beta shared their excitement. “I’m looking forward to testing the new features as a newbie developer,” added another X user .

The Texas Heart Institute Implants Artificial Heart - 2

Image by Coolarts223, from Deviantart

The Texas Heart Institute Implants Artificial Heart

  • Written by Kiara Fabbri Former Tech News Writer
  • Fact-Checked by Justyn Newman Former Lead Cybersecurity Editor

On July 25, a team at the Texas Heart Institute (THI) successfully implanted the world’s first BiVACOR Total Artificial Heart (TAH) in a human patient. This groundbreaking procedure marks a significant advancement in the treatment of severe heart failure, potentially offering a bridge to transplant for patients facing long wait times.

The BiVACOR TAH is a revolutionary device compared to existing total artificial hearts. Unlike traditional models that rely on flexible diaphragms, the BiVACOR TAH utilizes a single, magnetically levitated rotor (a significant design simplification). This translates to several key advantages. Firstly, the absence of mechanical bearings and moving parts minimizes wear and tear, potentially extending the lifespan of the device. Additionally, the BiVACOR TAH is capable of delivering high blood flow rates, even during exertion, mimicking the performance of a healthy heart. Finally, the implant is small enough to fit most adult patients, promoting better patient comfort and mobility.

Daniel Timms , PhD, Founder and Chief Technology Officer of BiVACOR said , “I’m incredibly proud to witness the successful first-in-human implant of our TAH. This achievement would not have been possible without the courage of our first patient and their family, the dedication of our team, and our expert collaborators at The Texas Heart Institute. Utilizing advanced MAGLEV technology, our TAH brings us one step closer to providing a desperately needed option for people with end-stage heart failure who require support while waiting for a heart transplant. I look forward to continuing the next phase of our clinical trial.”

Heart failure is a major global health concern affecting an estimated 64 million people worldwide . Unfortunately, heart transplants, the current gold standard for severe cases, are limited due to donor availability.

The successful implantation of the BiVACOR TAH represents a major leap forward in cardiac care. This innovative technology holds immense promise for improving outcomes and extending the lives of patients suffering from heart failure.